Aug 6, 2026 08:00AM
Jul 6, 2026 08:03AM
Jul 6, 2026 08:00AM
Jun 4, 2026 07:00AM
May 7, 2026 08:00AM
Mar 30, 2026 08:01AM
Mar 30, 2026 08:00AM Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Mar 23, 2026 08:03AM
Mar 23, 2026 08:00AM
Feb 26, 2026 06:00AM
Feb 19, 2026 06:00AM
Nov 4, 2025 06:00AM
Nov 3, 2025 06:00AM
Oct 15, 2025 06:01AM Aurinia to present LUPKYNIS data at medical conferences
Oct 15, 2025 06:00AM
Sep 30, 2025 05:01AM
Sep 30, 2025 02:37AM
Sep 29, 2025 08:27PM
Jul 31, 2025 06:00AM
Jul 30, 2025 06:34AM
Jul 22, 2025 06:00AM Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025
Jun 30, 2025 06:01AM
Jun 30, 2025 06:00AM
Jun 29, 2025 05:00PM
May 22, 2025 06:00AM
May 12, 2025 06:00AM
May 5, 2025 06:00AM
Apr 30, 2025 06:00AM Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
Apr 29, 2025 06:00AM
Feb 27, 2025 06:00AM
Feb 20, 2025 04:05PM
Nov 18, 2024 05:53PM
Nov 15, 2024 06:00AM
Nov 14, 2024 06:00AM
Nov 7, 2024 06:10AM Aurinia Pharmaceuticals (AUPH) Announces Board Changes
Nov 7, 2024 06:10AM
Nov 7, 2024 06:00AM
Oct 30, 2024 04:05PM
Oct 11, 2024 06:01AM
Oct 11, 2024 06:00AM
Sep 24, 2024 08:10AM
Sep 24, 2024 08:10AM Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis
Sep 13, 2024 06:00AM
Sep 12, 2024 04:05PM
Sep 12, 2024 04:05PM
Sep 6, 2024 06:53AM
Sep 5, 2024 07:22AM
Sep 5, 2024 06:00AM
Aug 28, 2024 06:00AM Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Aug 1, 2024 08:00AM

328,575 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All